ask="0.6850"
ask_size="1100"
average_daily_volume="527523"
bid="0.5850"
bid_size="900"
book_value="1.6420"
change="-0.0452"
change_from_200_day_moving_average="-0.4345"
change_from_50_day_moving_average="-0.0764"
change_from_52_week_high="-2.7752"
change_From_52_week_low="0.0745"
change_in_percent="-6.9538%"
close="0.6048"
dividend_pay_date="8/19/2015"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-1.5860"
ebitda="-16.45M"
eps_estimate_current_year="-1.5200"
eps_estimate_next_quarter="-0.4100"
eps_estimate_next_year="-1.2400"
ex_dividend_date="8/20/2015"
float_shares="5356000"
high="0.6699"
high_52_weeks="3.3800"
last_trade_date="1/17/2017"
last_trade_price="0.6048"
last_trade_size="1250"
last_trade_time="3:59pm"
low="0.5800"
low_52_weeks="0.5303"
market_capitalization="7.27M"
moving_average_200_day="1.0393"
moving_average_50_day="0.6812"
name="Catalyst Biosciences
Inc."
notes="N/A"
one_year_target_price="3.2500"
open="0.6400"
pe_ratio="N/A"
peg_ratio="0.0200"
percent_change_from_200_day_moving_average="-41.8092%"
percent_change_from_50_day_moving_average="-11.2171%"
percent_change_from_52_week_high="-82.1065%"
percent_change_from_52_week_low="+14.0486%"
previous_close="0.6500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.3959"
price_per_sales="17.8876"
revenue="437000.00"
shares_outstanding="12026000"
short_ratio="0.1200"
stock_exchange="NCM"
symbol="CBIO"
volume="259693"
weeks_range_52="0.5303 - 3.3800"
